PetMed Express, Inc. Q1 FY2027 earnings call

Core Strategic Priorities

• Central focus is driving long-term shareholder value and establishing a clear path back to sustainable profitability amid intense competition in the direct-to-consumer pet health market
• The Board evaluates all capital allocation and strategic priorities with strict discipline, and remains open to any opportunities that could enhance shareholder value
• Key transformation priorities include optimizing capital allocation, streamlining cost structure, developing new revenue streams, improving customer retention, lowering customer acquisition costs, modernizing technology infrastructure, enhancing customer service, and speeding up delivery times

Operational & Technology Updates

• Completed enterprise-wide rollout of SAP as the new ERP system in Q1, marking the completion of one of the largest components of the company's legacy technology platform replacement initiative, and strengthening financial and reporting processes
• A new call center platform launched in June to improve efficiency in handling customer inquiries and sales
• A fraud prevention system launched in the prior quarter continues to protect the business as order volumes evolve
• A new freight agreement mitigated proposed cost increases from the previous carrier, and improves delivery speed and tracking, with West Coast customers now receiving orders up to 2 days faster to boost customer satisfaction and retention

Customer Acquisition & Marketing Improvements

• The company is diversifying its customer acquisition funnel beyond increasingly expensive traditional advertising channels
• Acquired approximately 70,000 new customers in Q1, with this metric trending upward over multiple consecutive quarters
• Reduced cost per new customer by 15% year-over-year, from $71 to $60, driven by optimization of media spend and elimination of unproductive high-cost marketing programs
• Recurring revenue share of total gross sales has grown to 61.5%, reflecting a strengthening subscription-driven customer base

New Strategic Partnerships & Revenue Streams

• Launched its first large-scale white label/co-branded online pharmacy program with Rural King in July 2026, serving Rural King's 150+ stores across 17 states, bringing in-store shoppers to the PetMeds-powered platform and expanding access to pet medications in underserved rural communities
• The partnership serves as a proof of concept for the company's strategy to leverage its existing pharmacy infrastructure, licensed pharmacists, and e-commerce expertise to acquire new customers and develop incremental revenue streams, with additional white label partnerships expected to be announced soon

Corporate Updates

• The company received an unsolicited conditional proposal from Silver Cape Investments to acquire all outstanding shares for $3 per share in cash; the Board has not yet reached a determination on the proposal, and no assurance of a completed transaction can be given
• The Board is conducting a search for a permanent CEO with the support of a global executive search firm, and this search remains a high priority
• Entered into a definitive $37 million sale-leaseback agreement for the company's Delray Beach, Florida headquarters and distribution center; the transaction is expected to close within 120 days, will allow the company to continue leasing the required space for 10 years with renewal options, and unlocks real estate value to strengthen the balance sheet and provide additional financial flexibility for strategic initiatives

The transcript does not break out financial performance for multiple distinct product segments. Aggregate net sales for Q1 27 were $41 million, a 19.9% year-over-year decline from $51.2 million in the prior-year quarter, driven by broad softness in prescription medication sales. Recurring net sales (including auto-ship and membership revenue) accounted for 61.5% of total gross sales, up from 57.6% year-over-year. Gross profit totaled $11.3 million (27.6% of net sales), down from $14.4 million (28.1% of net sales) year-over-year. General and administrative expenses were $11.2 million, down 13.5% year-over-year from $12.9 million. Advertising expenses were $4.2 million, down 30.2% year-over-year from $6 million. Depreciation and amortization was $2.1 million, down from $2.3 million year-over-year. Net loss was $6.1 million ($0.28 per diluted share), narrowing from a net loss of $34.2 million ($1.65 per diluted share) in the prior-year quarter. Adjusted EBITDA loss was $3.4 million, compared to a $2.7 million loss year-over-year.

Management did not provide specific numerical forward guidance or explicit upward/downward revisions to prior guidance in this earnings call. Management only provided qualitative forward-looking commentary stating that completed operational, financial, and strategic improvements over the past 12 months have created a stronger, more scalable foundation that positions the company well to achieve its long-term goals of returning to sustainable profitability and driving shareholder value.

• Forward-looking statements made during the call are inherently subject to risks and uncertainties that could cause actual results to differ materially from projected outcomes, as detailed in the company's SEC filings including its most recent Form 10-K annual report
• The direct-to-consumer pet health market remains intensely competitive
• Traditional advertising and media channels for customer acquisition continue to become more expensive
• There is no assurance that the unsolicited acquisition proposal from Silver Cape Investments will result in a completed transaction
• The pending sale-leaseback transaction is subject to customary closing conditions including due diligence and final lease negotiation, so there is uncertainty around its completion timeline and final outcome

There were no questions asked or answered during this earnings call.